Senicapoc (ICA-17043) is a Gardos channel blocker.It has been proposed for use in sickle cell anemia.The Gardos channel has been identified as KCNN4.The ICA is for Icagen which is developing the drug.
This page contains content from the copyrighted Wikipedia article "Senicapoc"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
